The reduced expression of CACNA1C/Cav1.2 (ICa,L) has been shown to be associated with heart diseases, including atrial fibrillation [19–21], ventricular tachycardia [22], and dilated cardiomyopathy, contributing to the pathogenesis of arrhythmia. Here, CACNA1C is linked to heart disorder.